Published: 2/8/2022 3:07:46 PM

Nanologica: Q4 is a quarter with low sales activity - Redeye

The combination with easing COVID restrictions and the access to funds via Flerie Invest AB is a good combination that gives Nanologica an extended window of opportunity to establish sales and a commercial pipeline of interest in preparative chromatography. However, this is also a necessity that the low sales activity in Q4 confirms.

Link to the analysis

Read more about Nanologica AB